Carl Desantis - 15 Apr 2026 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: 10%+ Owner
Issuer ticker: INBP
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Apr 2026, 11:58:42 UTC
Prior SEC filing: 26 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ William H Milmoe, Personal Representative

Key filing fact

Carl Desantis filed Form 4 for INTEGRATED BIOPHARMA INC (INBP) on 17 Apr 2026.

Key facts

This page summarizes Carl Desantis's Form 4 filing for INTEGRATED BIOPHARMA INC (INBP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Apr 2026, 11:58.

Change

Previous filing in this sequence was filed on 26 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001102948 Primary reporting owner

DESANTIS CARL

Relationship: 10%+ Owner
Address: C/O CDS INTERNATIONAL HOLDINGS, 109 SE 5TH AVENUE, SECOND FLOOR, DELRAY BEACH
Signature: /s/ William H Milmoe, Personal Representative
Signature date: 17 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBP transaction

Common Stock

Gift

Transaction value
Shares: -8,966,547
Change %: -80%
Price: $0.000000^*
Shares after: 2,235,417
Date: 15 Apr 2026
Ownership: Reporting Person is deceased
Footnotes: F1

INBP transaction

Common Stock

Gift

Transaction value
Shares: -2,235,417
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Apr 2026
Ownership: Reporting Person is deceased
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Carl Desantis is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Footnote F2

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.